INTRODUCTION
The three virus groups to be considered are the lymphoid leukosis viruses (LLV), the acute leukaemia viruses, also called the defective leukaemia viruses (DLV) since they are all defective for replication, and the avian sarcoma viruses, ASV. Avian retroviruses are divided into these groups on the basis of the spectrum and latency of the neoplasia they induce in vivo (Table 1) . Although this method of classification is by no means absolute, there being many overlaps, it does provide an easy basis upon which to consider these viruses. When considering the mechanism of transformation the most important feature of this classification is the latency period. Viruses which transform rapidly, DLV and ASV, appear to do so by virtue of cellular sequences which have been incorporated into the genome which encode a protein(s) that is responsible for transformation. The method by which viruses with a long latency transform cells is poorly understood but it appears to involve more indirect mechanisms.
Lymphoid leukosis viruses ( LL V)
Lymphoid leukosis viruses cause disease, the clinical manifestations of which are only obvious after a long latency period, usually 4 months or more. It should be mentioned, however, that preneoplastic lesions can be seen within individual follicles in the bursa within 4 weeks (Cooper et al., 1978) . The predominant neoplasm they induce is a B cell lymphoma which usually arises in the bursa of Fabricius and may metastasize to other organs. They are, however, capable of causing a variety of other tumours of which nephroblastoma, osteopetrosis and erythroblastosis are perhaps the most common. In considering how the LLV induce these diseases the two central points which have to be kept in mind are the long latency period required for appearance of disease and the specificity of transformation, namely the predominance of bursal lymphomas over other tumours.
The LLV are replication competent viruses, unlike all of the DLV and most of the ASV. They possess three genes which are arranged on the genomic RNA as depicted in Fig. 1 . The gag gene codes for a 76 000 mol. wt. protein Pr76, the precursor to the core proteins of the virion which are derived from it by proteolytic cleavage. The pol gene codes for the RNA-dependent DNA polymerase of the virion, sometimes called the reverse transcriptase. The env gene codes for the virion glycoproteins gp85 and gp37 which are synthesized as a glycosylated precursor of 95 000 mol. wt., gPr95, which is then cleaved to produce the virion glycoproteins (for review, see Eisenman & Vogt, 1978) . These are the only proteins that the LLV genomic RNA is known to code for. All are essential for virus replication and are not thought to have any other function. How then do the LLV induce lymphoid leukosis? Until recently there were essentially no viable theories but recent observations on the replicative cycle of the virus have provided information that has led to certain interesting speculations.
Upon infection of cells the single-stranded RNA of the virus is transcribed into a double-stranded DNA copy and this proviral DNA is then integrated into the chromosomal DNA of the cell. The mechanism of these events is outside the scope of this review but interested readers will find information on this topic excellently covered in Bishop (1978) and the Cold Spring Harbor Symposia vol. 44 (1980) . The important feature of these events with regard to putative mechanisms of pathogenesis is the structure of the integrated provirus, depicted in Fig. 1 . The integrated proviral DNA is co-linear with the virus RNA but the coding sequences are now flanked by sequences designated long terminal repeats (LTR). The LTR are composed of sequences derived from the 3' end of the genome together with sequences derived from the 5' end of the genome (see Fig. 1 ). The LTR have many interesting structural features which may be important for transcriptional control, the most important of which is a candidate promoter sequence, indicated in Fig. 1 . Since the LTR are present at both ends of the proviral sequences it is possible that in addition to the proposed promoter for virus transcription, the repeated promoter sequence downstream might be responsible for promotion of transcription of normal cellular genes (see Fig. i ). Downstream promotion would produce messenger RNA species containing both viral and cellular sequences and such mRNAs have been found in the majority of bursal tumours examined (Hayward et al., 1981; H. E. Varmus, personal communication) . This increased expression of normal cellular genes as a result of a virally coded promoter has given rise to the 'promoter insertion' model of leukaemogenesis (Hayward et al., 1981; Tsichlis & Coffin, 1980) . Although the integration of proviral DNA appears to take place at many sites in the chromosomal DNA and may indeed be random, analysis of the sites of integration of the provirus in bursal tumours has revealed the following interesting observations: (i) there appear to be a limited number of classes of integration sites as judged by restriction enzyme analysis, therefore giving rise to a limited number of mRNAs (Hayward et al., 1981) and (ii) many of the integrated proviruses appear defective in that they have suffered deletions at the 5' end including the upstream promoter for transcription of proviral DNA (H. E. Varmus et al., personal communication) . Therefore, the cellular sequences that are expressed due to the insertion of the viral downstream promoter may represent a limited number of specific sequences that are responsible for the oncogenic transformation of the lymphocytes. There is as yet no evidence that the expression Cooper & Neiman (1980) demonstrated that DNA extracted from LLV-induced bursal lymphomas was much more active in transforming NIH-3T3 mouse cells in transfection experiments than was DNA from LLV-infected but non-transformed tissue. Importantly, examination of DNA from the transformed NIH-3T3 cells by restriction enzyme digestion and Southern blotting revealed that it did not contain any LLV-related DNA, not even LTR sequences containing the promoter region. The implication is that the LLV-induced tumours contain cellular transforming genes, as detected by transfection, which are not linked to LLV DNA sequences. These data indicated that LLV infection of bursal lymphocytes occasionally leads to the activation of cellular genes by some indirect mechanism, perhaps by the rearrangement of cellular genes by virus-induced mutagenesis. The tumours which arise would do so as a result of this abnormal gene expression. These rearrangements may involve many steps before the cells become truly malignant and may explain why there is such a long period of time between the appearance of the preneoplastic lesions and the clinical appearance of the disease . As mentioned earlier, the two central observations that have to be explained by any theory of LLV-induced leukaemogenesis are the long latency period prior to the manifestations of the disease and the predominance of B cell lymphoma. So far there is no evidence that LLV-induced tumours occur as a consequence of the action of a LLV gene or as the result of the formation of a recombinant virus. The two theories outlined above postulate that transformation results from the activation of cellular genes, although they differ in the description of the mechanism by which this occurs. Why this activation requires such long latency and why it preferentially occurs in bursal lymphocytes, are questions which remain to be answered. Until they are, LLV-induced leukaemogenesis remains a mystery.
Defective leukaemia viruses ( DL V)
Upon infection of young chickens these viruses rapidly bring about the death of the birds from a variety of neoplasms, usually, but not exclusively, of the haematopoietic system . Seven different strains of DLV, all of which are field isolates, will be considered here, and are listed in Table 2 , together with the neoplasms that they induce. Experimental manipulation of these viruses has been greatly facilitated by the discovery of their ability (with the exception of AMV) to transform fibroblasts in culture and also by the establishment of in vitro assays for the transformation of chicken bone marrow cells (Baluda & Goetz, 1961; Langlois et al., 1969; Moscovici et aL, 1975; Graf, 1975; Graf et al., 1979) . As mentioned earlier these viruses are defective for replication and consequently the field isolates are complex mixtures of replication-competent LLV helper viruses together with the DLV. However, since DLV can transform cells in vitro, unlike the helper LLV it is possible to isolate clones of transformed cells which only contain the genome of the DLV. These cells obviously are incapable of releasing infectious DLV and are called M.J. HAYMAN non-producer cells. The DLV genome can be rescued from the non-producer cells by superinfection with a well-characterized helper virus, giving rise to a defined infectious virus complex. Using these virus complexes in the in vitro assays for the transformation of chicken bone marrow cells, the seven DLV isolates were divided into three groups on the basis of the phenotype of the transformed haematopoietic cells Beug et al., 1979 ; Table 2 ). Specifically, four of the DLV (MC29, CMII, MH-2 and OK10) transform cells which resemble macrophages whereas AMV and E26 transform ceils resembling myeloblasts and AEV-transformed cells are erythroblasts. The phenotype of the transformed cells was found to be independent of the helper virus, so implying that the specificity of the transformation was a direct consequence of some property of the DLV genome. To my mind this is a central feature of transformation by DLV and any model for transformation has to take this property into account; that is, why does AEV only transform cells of the erythroid lineage upon infection of bone marrow and conversely why does MC29 only transform cells resembling macrophages? It is also important to note that although these viruses have this target cell specificity for the transformation of haematopoietic cells they are all, with the notable exception of AMV, capable of transforming fibroblasts in vitro, and in vivo they are capable of causing non-haematopoietic diseases with high frequency, in particular sarcomas (AEV) and liver and kidney turnouts (MC29-type viruses). With these considerations in mind a description of what is known of the genome structure and gene products of the DLV will be given.
MC29-type strains. MC29 was the first DLV to be studied in any detail. Complementary DNA (cDNA) was prepared that was specific for MC29 by reverse transcription of genomic RNA followed by pre-hybridization of this eDNA with avian leukosis virus RNA and selection of the non-hybridized fraction. This procedure removes cDNA sequences which MC29 shares with avian leukosis viruses and the residual cDNA could then be shown to hybridize only with MC29 genomic RNA. Additionally, it was shown that this MC29-specific probe also hybridizes with uninfected chicken cell DNA, indicating that it was detecting cellular sequences which are now present in the virus genome (Roussel et al., 1979) . When the genomic RNA of the other DLV was hybridized with this cDNA it was found only to hybridize to the members of the biological group of which MC29 itself was a member, i.e. it hybridized with CMII, OK10 and MH-2 genomic RNA but not with AEV, AMV or E26 genomic RNA (Roussel et al., 1979; Stehelin et al., 1980) . When similar cDNA probes were prepared which were specific for AEV or AMV comparable results were found. Namely, these probes only hybridized to genomic RNA from members of their own biological groupings and to cellular DNA (Roussel et al., 1979; Stehelin et al., 1980) . Therefore, the conclusions from these hybridization studies were that all seven DLV contain cellular sequences within their genomes and perhaps most importantly, viruses which have acquired the same or similar cellular sequences have very similar transforming capabilities. These sequences were named after the phenotype of the haematopoietic cells transformed in vitro. Thus the sequences in the MC29-type virus genomes were called mac for macrophage, the AMV and E26 sequences were named myb for myeloblasts and the AEV sequence erb for erythroblast (Stehelin et al., 1980; Graf et al., 1980) . It is important to note that the names do not imply that the sequences necessarily represent genes nor that the sequences are identical in similar viruses. In fact the myb sequences in AMV and E26 are known to differ quite markedly (Roussel et al., 1979) . This nomenclature merely implies that the sequences are highly related and probably code for proteins which have a similar function.
The location within these virus genomes of these inserted cellular sequences in the case of MC29, MH-2 and CMII was deduced from oligonucleotide and heteroduplex mapping studies on the genomic RNA (Mellon et al., 1978; Lai et al., 1979; Hu et aL, 1979; ) and these are shown in Fig. 2. Fig. 2 structure of the other DLV in this group, OK10, as deduced from an analysis of OK10-specific proteins found in non-producer cells and oligonucleotide mapping studies . In each case the cellular sequences appear to have been inserted within the genome of a LLV and this substitution has been at the expense of a variable amount of structural information, giving rise to a virus which has lost the ability to replicate but has acquired the ability to transform certain types of cells. The specificity of the transformation seems to depend on the cellular sequences acquired. The studies to identify any DLV-specific gene products were performed first on non-producer fibroblasts transformed by MC29. An immunological analysis revealed that none of the normal viral structural proteins were present in these cells. Instead a single protein of 110000 mol. wt., p110, was found (Bister et al., 1977) . Immunological analysis showed that p110 was related to the gag gene but not to thepol or env gene products (Hayman et al., 1978) and tryptic peptide mapping experiments further demonstrated that this protein only contained tryptic peptides from the amino terminal half of the gag gene product Hayman et al., 1980) . Similar analyses were carried out with non-producer cells transformed by MH-2 (Hu et al., 1978) , CMII (Hayman et al., 1979a; Bister et al., 1979) and OK10 . In the case of MH-2 and CMII, proteins were found that comprised variable amounts of the amino terminal sequences of the gag gene product with the carboxy terminal region of the protein, being unrelated to any of the other viral structural gene products (Fig. 2) . In the case of OK10 the gag gene product Pr76 gag, together with a protein of 200 000 mol. wt. which contains the whole of the gag gene, almost all of the pol gene plus the mac gene product, were found . In addition, tryptic peptide fingerprint analysis of the pll0 of MC29 and the p90 of CMII revealed extensive homology between the non-viral sequences of these proteins . Since these latter two viruses belong to the same biological group it appeared that the carboxy terminal half of these proteins was translated from the mac sequences, a result which was in accord with the oligonucleotide mapping studies and in vitro translation of MC29 genomic RNA (Mellon et al., 1978) . Therefore, for MC29, CMII, MH-2 and OK10 it appears that the acquired cellular sequences are expressed as a fusion protein comprising part of the gag gene product together with the cellular sequence product (Fig. 2) . These proteins seem to be the only gene products found so far in cells transformed by this group of viruses and as such represent the best candidates for transforming proteins.
AEV. As mentioned above, the AEV genome was found to contain inserted cellular sequences defined as the erb sequences (Roussel et al., 1979) and analysis of AEV non-producer cells by immunoprecipitation revealed the presence of a gag-related protein, p75 (Hayman et al., 1979b) . This protein again could be shown to be comprised of the NH 2 terminal gag protein, p19, plus non-viral sequences and these additional sequences were distinct from those in MC29 p110 and CMII p90 . So far the situation was very similar to that found with the MC29-type DLV, but in the case of AEV this is not the whole story, since heteroduplex mapping studies defined the size of the cellular insert at approx. 3.25 Kb . This is enough information to encode over 100000 daltons of protein, only approx. 50000 daltons of which can be accounted for within the AEV p75 gag-related protein (Hayman et al., 1979b; Rettenmier et al., 1979) . Furthermore, in vitro translation of partially degraded AEV virion RNA revealed that there was an AEV-specific protein of 40 000 daltons, p40 AEV, in addition to p75 (Lai et al., 1980; Yoshida & Toyoshima, 1980; Pawson & Martin, 1980; Hayman et al., 1980) and this protein was translated from an 18 to 20S RNA. Therefore, the erb sequences within the AEV genome have the capability to encode two proteins, one gag-related and one not (Fig. 2) , and candidate mRNA molecules for both these proteins have been detected in AEV-transformed cells Vennstrom et al., 1980 
; S. Saule et aL, personal communication).
AMV-type strains. Work on these viruses has been hampered by two problems: the limited availability of the E26 strain and the inability of AMV to transform fibroblasts. Non-producer myeloblasts transformed by these two viruses have proven difficult to analyse biochemically due to their poor growth properties and the low amounts of virus proteins synthesized. Some work has been done using specific eDNA probes as described above (Roussel et al., 1979, and personal communication) . Also, the molecular cloning of the AMV genome has been reported recently (Souza et al., 1980; Bishop et al., 1980) and from these data the structure of the genome of AMV can be deduced (Fig. 2) . The cellular sequence, myb appears to have been substituted for the env gene in AMV, implying that there should be no fusion product of a viral structural gene product and the product coded for by myb sequences. Instead myb would be predicted to be translated from a subgenomic mRNA and indeed a potential mRNA of 18 to 20S has been detected in AMV-transformed non-producer cells (M. Roussel et al., personal communication; J. M. Bishop et al., personal communication) . Therefore, the identification of any gene product within transformed cells awaits the production of a rnyb-specific antiserum or the in vitro translation of the myb-specific mRNA.
With E26 the nucleic acid hybridization data give rise to the hypothetical genome structure depicted in Fig. 2 . In this case one may expect to find a gag-related fusion product and a gag-related molecule of 130000 mol. wt. has been found (H. Beug, personal communication) . Whether an additional protein exists, which only contains myb sequences, awaits the isolation of a myb-specific antiserum.
The genome structures of the DLV are depicted in Fig. 2 , together with the gene products which are coded for by the acquired cellular sequences. That these proteins have anything to do with the transforming activity of the DLV is in the main based on circumstantial evidence. There are, however, a few recent genetic experiments which would seem to implicate the acquired cellular sequences in the transforming event. Two mutants of AEV have been described which are altered in their transforming ability: one is a conditional mutant and the other is non-conditional. The conditional mutant, ts34, is temperature sensitive for the transformation of erythroblasts; at the non-permissive temperature of 41 °C the cells differentiate and start to synthesize haemoglobin and erythrocyte antigens Savin & Beug, submitted) . In addition, fibroblasts transformed by this mutant are temperature sensitive for certain transformation parameters . As yet, the mutation in ts34 has not been mapped, but the existence of this ts mutant does imply that a viral gene product is involved in the maintenance of the transformed phenotype of both AEV-transformed erythroblasts and fibroblasts. At the non-permissive temperature p75 is synthesized, phosphorylated and the turnover rate is the same as that observed at 35 °C (M. J. Hayman & H. Beug, unpublished observations) and until some function has been assigned to either of the AEV-specific proteins it will prove very difficult to decide where the presumed point mutation of this ts mutant resides. The non-conditional mutant, td359, is unable to transform erythroblasts but has retained the ability to transform fibroblasts . The mutation in this virus has been mapped as a small deletion in that region of the erb sequence which codes for the p75; the size of the p40 protein is unaffected (Beug et aL, 1980a, b) . Similarly, three non-conditional MC29 mutants have been isolated which transform haematopoietic cells with a greatly reduced efficiency but have retained the ability to transform fibroblasts . All three of these mutants make smaller gag-related proteins of sizes pl00, p95 and p90 compared to the wild-type p110 . Biochemical analysis of the mutant proteins and genomic RNA revealed that they have suffered deletions within the mac sequences (G. Ramsay, K. Bister, M. J. Hayman & P. H. Duesberg, unpublished observations) . These studies with the non-conditional mutants of AEV and MC29 strongly implicate the cellular sequences in the virus-induced transformation. That they have retained the ability to transform fibroblasts is probably best explained by arguing that more biologically active protein is required to transform haematopoietic cells than fibroblasts and the small deletions have reduced the activity of the gag-related proteins to a level that is insufficient to transform haematopoietic cells. The general conclusion from these studies is that the DLV transform cells by virtue of the acquired cellular sequences. The expression of the proteins coded for by these sequences depends on their position within the genome. Whilst some knowledge of the structure of the viral genomes and the proteins they encode is being accumulated, our understanding of the mechanism by which transformation is accomplished is still in its infancy. As discussed earlier, a central feature of transformation by DLV is the specificity of haematopoietic cell transformation. Since we now know that viruses with different specificities carry different genes this observation can be explained by hypothesizing that the target cells for transformation have specific receptors which interact with the gene product specified by the cellular gene that the DLV has acquired. One prediction arising from this hypothesis would be that the various DLV should infect and replicate in non-target cells. Thus, AEV should replicate in macrophages, synthesize p75, but these cells should not be transformed. Conversely, MC29 should be able to replicate in erythroblasts without causing transformation. Indeed, this was found to be the case . Unfortunately, the experiments are not fully definitive as MC29 was shown to replicate only in erythroblasts already transformed by AEV, since at present it is impossible to isolate pure populations of uninfected erythroblasts. However, with this proviso, the available data fit the hypothesis so far. The nature of our understanding of transformation by the DLV is still rudimentary. Although it is possible to postulate the presence of specific receptors which are only expressed in certain cells we have no information on the identity of these receptors, their ultrastructural location within the cell or the nature of the interaction between the transforming protein and the receptor. Is this interaction enzymic or conformational in nature? Why can MC29 transform fibroblasts, epithelial cells and macrophage-like cells and yet not transform erythroblasts? If the specificity of transformation reflects the presence of intracellular receptors why should they be present in such diverse cell types and absent in others? Before we truly understand transformation by DLV all these questions will have to be answered.
Avian sarcoma viruses
Until recently the work on ASV had concentrated solely on Rous sarcoma virus (RSV) and this virus was considered to be the prototype of the sarcoma viruses. Retrospectively it would appear that the genome structure of RSV represents the exception rather than the rule. Like the DLV discussed above, sarcoma viruses have the ability to cause sarcomatous transformation by virtue of acquired cellular sequences. Unlike the DLV and the other ASV, the cellular sequence in the case of RSV has been inserted between the env gene and the 3' end of the genome of a LLV, rather than substituted for replicative genes (Fig. 3) . Consequently RSV possesses the novel feature of being able to both replicate in and transform fibroblasts, something that no other rapidly transforming retrovirus isolated so far can do. The other ASV [PRCII, Fujinami sarcoma virus (FSV) and Y73] have similar genome structures to the DLV and are replication defective. All three synthesize fusion proteins of the gag gene and the acquired sequences (Fig. 3) and these proteins are presumed to be responsible for transformation (Hanafusa et al., I980; Lee et al., 1980; Breitman et al., 1980; Neil et al., 1980; Kawai et al., submitted) . The ability of RSV to replicate as well as transform means that it is the ideal model virus with which to study transformation, since the virus genome can be isolated for analysis in a pure state and not as a complex with helper virus. The virus can also be mutagenized and single clones of mutant virus which can no longer transform can be isolated. Biochemical studies in concert with genetic analysis rapidly established that RSV contained a transforming gene termed sre which was derived from a Review: Avian retroviruses cellular gene (for reviews, see Bishop, 1978; Vogt & Hu, 1978; Wang, 1978; Coffin, 1979) . This gene was subsequently shown to code for a protein of 60000 mol. wt. using antiserum from rabbits with RSV-induced tumours (Brugge & Erikson, 1977) . This protein was later shown to be a phosphoprotein (Brugge et al., 1978 a; Levinson et al., 1978) and to possess the ability to phosphorylate proteins in an immune complex assay (Collett & Erikson, 1978; Levinson et aL, 1978) and is referred to as pp60 src. That the kinase activity was inherent to pp60 src could be demonstrated by the criteria that it co-purifies with the protein (Erikson et al., 1980) and appears following in vitro translation ofsrc mRNA into pp60 sre (Enkson et al., 1978; Sefton et al., 1979) . In addition, studies with mutants temperature sensitive for transformation have shown that the pp60 sre of the mutants is a thermolabile protein kinase both when assayed in vivo and in vitro (Levinson et al., 1978; Collett & Erikson, 1978; Collett et al., 1979; Rubsamen et al., 1979; Bishop et al., 1980; Sefton et al., 1980) . Similar studies on non-conditional mutants in src have also implicated this kinase in transformation . The kinase has been shown to be novel in that it phosphorylates tyrosine, rather than the more commonly phosphorylated amino acids serine and threonine, in the in vitro assays (Hunter & Sefton, 1980) and RSV-transformed cells have increased levels of phosphotyrosine (Hunter & Sefton, 1980; Sefton et al., 1980) . Two-dimensional peptide mapping analysis of phosphoproteins in transformed cells has identified a candidate substrate for pp60 s~c as a 34000 mol. wt. protein which is phosphorylated on a tyrosine residue (Radke & Martin, 1979; Hunter & Sefton, 1980) . This protein has recently been isolated and shown to be readily phosphorylated in vitro by purified pp60 sre (E. Erikson et al., personal communication) . Immune precipitation of extracts from transformed cells has also identified a 50000 and an 80000 mol. wt. phosphoprotein which co-precipitate with pp60 src (Sefton et al., 1978; Hunter & Sefton, 1980) . This 50000 mol. wt. protein is also phosphorylated on a tyrosine residue (Hunter & Sefton, 1980) . Therefore, in contrast to all the other viruses discussed so far, the transforming protein of RSV has been identified, an enzymic activity has been assigned to this protein and possible substrates for the enzyme identified.
As mentioned above, the src gene is derived from a cellular gene and the cellular gene products have been identified in uninfected cells from both mammalian and avian species (Oppermann et al., 1979; Brugge et al., 1979) . This protein too was shown to be a 60000 mol. wt. kinase, pp60 ~-s'~, and to be located in the plasma membrane (Oppermann et aL, 1979; Courtneidge et al., 1980) . Transformation by RSV can then be considered to be due to the expression of a normal cellular protein kinase which is produced in virus-infected cells at 50-to 100-fold higher levels than in uninfected cells (Oppermann et al., 1979) . This hypothesis is based on the assumption that the cellular src protein is important for growth control, and that when present above a basal level it causes the cells to divide, presumably the level of pp60 ~s~c normally being controlled by the cell. The virally coded src is under the control of a virus promoter and is constantly expressed at high levels so the cells keep dividing and therefore are transformed. This hypothesis, while probably true, begs the question of how the protein causes transformation.
RSV-transformed cells differ in vitro from their uninfected counterparts most strikingly in their morphology and their ability to grow in semi-solid media. These features of cellular transformation have caused speculations that pp60 ~ may act on the cytoskeletal system of the cell (Ash et al., 1976; Collett & Erikson, 1978; Edelmann & Yahara, 1976) , an hypothesis which is made more attractive by the recent observations that the src gene product can affect cellular morphology and actin cables in enucleated cells . Ultrastructural studies on the location of pp60 sre within cells have shown it to be cytoplasmic but with a significant proportion of the protein on the cytoplasmic face of the plasma membrane (Rohrschneider, 1979; Brugge et al., 1978b; Willingham et al., 1979; Krueger et al., 1980; Courtneidge et al., 1980) . However, recently evidence has been obtained that pp60 s'c may indeed be associated with the cytoskeletai matrix (Burr et al., 1980) and immunofluorescence has detected some pp60 src in adhesion plaques (Rohrschneider, 1980) . Furthermore, the pp60 sre found associated with the cytoskeleton could be shown to possess kinase activity in an in situ assay in which pp60 sre and two additional proteins of 50000 and 68 000 mol. wt. were phosphorylated (Burr et al., 1980) . The 50000 mol. wt. protein may be the same as that described by Sefton et al. (1978) . Therefore, these experiments suggest that at least one of the interactions in which pp61Y re is involved concerns the cytoskeletal matrix. In trying to reconcile these observations with those of pp60 ~ being found on the cytoplasmic face of the plasma membrane (WiUingham et al., 1979; Courtneidge et al., 1980) one is faced with the difficulty that it is not known whether a cytoplasmic face plasma membrane protein would be considered part of the cytoskeletal structure as defined by its insolubility in a 1% solution of a non-ionic detergent, especially since a large number of plasma membrane glycoproteins are found attached to the cytoskeleton under these conditions (S. Penman, personal communication). The amino acid sequence, as deduced from the nucleotide sequence of the src gene, would predict that pp60 ~ is composed of an amino terminal hydrophobic domain of 15000 mol. wt. and the rest of the molecule carries the protein kinase . This structure would fit very well with the membrane location of pp60 ~c. Therefore, pp60 s~c may be located in the plasma membrane on the cytoplasmic face and interact with proteins of the cytoskeleton and also with other proteins, either in the membrane or in the cytoplasm. However, it should be mentioned that the src gene product appears to be responsible for many different pleiotypic effects (Becker et al., 1977; Weber & Friis, 1979) and it may be simplistic to think that pp60 sr~ has only one intracellular target and site of action.
As mentioned previously the other ASV are defective for replication and their genome structures are very similar to those of the DLV, containing inserts of sequences which are derived from cellular sequences (Hanafusa et al., submitted; Yoshida et al., submitted) . The cellular sequences that have been acquired by FSV appear to be related to those acquired by PRCII (Hanafusa et al., submitted) and because of this, both are known asfps. As would be expected, tryptic peptide mapping of the gag-related protein of F SV, p 140 and the p 105 of PRCII has shown that these proteins share non-gag peptides (J. C. Neil, personal communication) . In addition, both these proteins appear to be protein kinases which phosphorylate tyrosine (J. C. Neil, personal communication) . Interestingly, nucleic acid hybridization studies have also shown that thefps sequence in FSV is related to the cellular sequences that have been acquired by the Gardner-Arnstein and Snyder-Theilen strains of feline sarcoma viruses. Therefore, it appears that related sequences have been acquired by these viruses, in one case the avian cellular sequence and in the other the equivalent feline cellular sequence. The cellular sequences acquired by the Y73 virus appear to be unique to this virus and are expressed as a p90 gag-related protein (Kawai, submitted). It has not yet been reported whether this protein is also a protein kinase. Nothing is known about the cellular location of any of these three proteins and no candidate substrates for the kinase have been identified.
In summary, ASV transform cells by virtue of synthesizing proteins which are coded for by sequences that were originally derived from the cellular sequences. To date, three distinct sequences have been identified that have been acquired by these viruses: the src gene sequence, the fps sequence and the Y73 sequence. In two of these cases, and perhaps in all three, these sequences code for protein kinases which phosphorylate tyrosine. Therefore, studies on ASV seem to have revealed a central mechanism by which cells can be transformed.
Review: Avian retroviruses 11 Transforming proteins of mammalian retroviruses
Although this review is concerned with the transforming proteins of avian retroviruses it is perhaps germane to mention that the central features of transformation by the avian viruses are shared with the mammalian viruses. Mammalian viruses that transform cells rapidly also appear to do so by virtue of acquired cellular sequences. All rapidly transforming mammalian retroviruses analysed to date are replication defective and some of these acquired cellular sequences are expressed as gag-related proteins. Examples of these would be the p120 of the Abelson murine leukaemia virus, which is also a plasma membrane-located protein kinase that phosphorylates tyrosine (for review, see Rosenberg & Baltimore, 1980 ) and the gag-related proteins of the three feline sarcoma viruses, p 100 of the Gardner-Arnstein strain, the p78 of the Snyder-Theilen strain and the pl80 of the McDonough strain (Ruscetti et al., 1980) . There are also mammalian retroviruses in which the putative transforming protein is synthesized purely from the acquired cellular sequences which contain no viral structural information, for example the Harvey and Kirsten murine sarcoma virus p21 phosphoproteins (Shih & Scolnick, 1980) . Similarly the mammalian retroviruses which cause leukaemia only, after a long clinical latency, do so by mechanisms that have eluded investigations to date. Therefore, the general strategies of transformation by retroviruses seem to be the same regardless of the species of the virus.
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